🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

VahatiCor's A-FLUX Reducer System was featured on @EuroIntervention’s YouTube channel. Dr. Jean-Michel Paradis shared the first-in-human experience with our promising therapy. 📺 Watch the full interview: youtu.be/pe6dJvZ6kcM?si… #AFLUXReducer #microvasculardisease

📌NEW ISSUE OUT📌 ✅The 18th EBC consensus document; ✅Morphofunctional assessment in ACS patients; ✅OCT-guided PCI in STEMI patients; ✅A debate on bivalirudin; ✅The A-Flux − a selfexpanding coronary sinus reducer; ✅5-year outcomes of the ACURATE neo AS study; and more

VahatiCor's A-FLUX Reducer Therapy was selected for the EMA's Scientific Advice Pilot program! This aligns us with EMA to expedite CE-Mark approval. Exciting times ahead! #Cardiology #coronary #AFLUX #CMD #interventionalcardiology #microvasculardysfunction #EMA #cardioX

Cardiologists detail world’s first implant of new device for ‘no-option’ chest pain patients IUCPQ-ULaval VahatiCor #cardiology ow.ly/B8Qp50T2tQB